I
Innate Pharma SA D
D
IPHA
2.18000
USD
0.02
(0.93%)
مغلق
حجم التداول
540
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
200,904,000
الأخبار المقالات
العنوان: Innate Pharma SA
القطاع: Healthcare
الصناعة: Biotechnology
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.